Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Carcinoid Tumor × pasireotide × Clear all

Phase

Phase 2 2 Phase 1 2 Phase 3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Pituitary Neoplasms 2 Gastro-enteropancreatic neuroendocrine tumor 2 Acromegaly 2 Pancreatic Neoplasms 1 Lymphoma, Follicular 1 Growth Disorders 1 Gigantism 1 Carcinoid Tumor 1

Interventions

Octreotide 3 lanreotide 2 Everolimus 2 pasireotide 1 Sunitinib 1 Serotonin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00690430 2013-07-30

Efficacy and Safety of Pasireotide Long Acting Release vs. Octreotide Long Acting Release in Patients With Metastatic Carcinoid Disease

Novartis

Phase 3 Completed

186 enrolled 11 charts

Carcinoid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡